| Organism | Feature Type | Feature ID | Info | Relationship | Display | Orthologous Group | Coexpression Group |
|---|---|---|---|---|---|---|---|
| Glycine max | mRNA | Glyma.03G159300.1.Wm82.a2.v1 | Glyma.03G159300.1 | gene polypeptide | gma_coexpr_cluster_0003 | ||
| Glycine max | mRNA | Glyma.03G159400.4.Wm82.a2.v1 | Glyma.03G159400.4 | gene polypeptide | gma_coexpr_cluster_0003 | ||
| Glycine max | mRNA | Glyma.03G159500.1.Wm82.a2.v1 | Glyma.03G159500.1 | gene polypeptide | PTHR10825//PTHR10825:SF28 - RING FINGER DOMAIN-CONTAINING, POLYCOMB GROUP COMPONENT // SUBFAMILY NOT NAMED (1 of 2) | gma_coexpr_cluster_0003 | |
| Glycine max | mRNA | Glyma.03G161800.1.Wm82.a2.v1 | Glyma.03G161800.1 | gene polypeptide | PTHR13902:SF55 - TRANSCRIPTION FACTOR EMB1444-RELATED (1 of 5) | gma_coexpr_cluster_0003 | |
| Glycine max | mRNA | Glyma.03G162300.1.Wm82.a2.v1 | Glyma.03G162300.1 | gene polypeptide | PTHR14155//PTHR14155:SF178 - RING FINGER DOMAIN-CONTAINING // SUBFAMILY NOT NAMED (1 of 7) | gma_coexpr_cluster_0003 | |
| Glycine max | mRNA | Glyma.03G162400.1.Wm82.a2.v1 | Glyma.03G162400.1 | gene polypeptide | PF00847 - AP2 domain (AP2) (1 of 354) | gma_coexpr_cluster_0003 | |
| Glycine max | mRNA | Glyma.03G167500.1.Wm82.a2.v1 | Glyma.03G167500.1 | gene polypeptide | PF00069//PF08263//PF13855 - Protein kinase domain (Pkinase) // Leucine rich repeat N-terminal domain (LRRNT_2) // Leucine rich repeat (LRR_8) (1 of 85) | gma_coexpr_cluster_0003 | |
| Glycine max | mRNA | Glyma.03G167700.1.Wm82.a2.v1 | Glyma.03G167700.1 | gene polypeptide | gma_coexpr_cluster_0003 | ||
| Glycine max | mRNA | Glyma.03G168600.1.Wm82.a2.v1 | Glyma.03G168600.1 | gene polypeptide | PTHR15288 - SUPPRESSION OF TUMORIGENICITY 5 ST5 (1 of 6) | gma_coexpr_cluster_0003 | |
| Glycine max | mRNA | Glyma.03G169400.2.Wm82.a2.v1 | Glyma.03G169400.2 | gene polypeptide | gma_coexpr_cluster_0003 |